IMVT
Immunovant, Inc. · Healthcare
CTO Jay S Stout sold $32K of Immunovant, Inc.
Sold$31,914
$26.53Price
1,203Shares
−1%Stake
What IMVT did after the filing
- The stock from Mon, Jan 12 open, $26.04
- +4.6%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Feb 25 close.
Traded Wed, Jan 7. Filed Fri, Jan 9, 4:03 PM ET, after the close. Returns use the Jan 12 open and the Feb 25 close. Not investment advice.